Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

• Ahmed B. Bayoumy,
• Elsa L. S. A. van Liere,
• Melek Simsek,
• Ben Warner,
• Aathavan Loganayagam,
• Jeremy D. Sanderson,
• Simon Anderson,
• Jonathan Nolan,
• Nanne K. de Boer,
• Chris J. J. Mulder,
• Azhar Ansari

Affiliations

Ahmed B. Bayoumy

Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre

Elsa L. S. A. van Liere

Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre

Melek Simsek

Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre, AG&M Research Institute

Ben Warner

Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation Trust

Aathavan Loganayagam

Department of Gastroenterology, Queen Elizabeth Hospital

Jeremy D. Sanderson

Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation Trust

Simon Anderson

Department of Gastroenterology, Guy’s and St Thomas’ NHS Foundation Trust

Jonathan Nolan

Department of Gastroenterology, Surrey and Sussex NHS, Easy Surrey Hospital

Nanne K. de Boer

Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre, AG&M Research Institute

Chris J. J. Mulder

Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre

Azhar Ansari

Department of Gastroenterology, Surrey and Sussex NHS, Easy Surrey Hospital